Algeria Drug Patents

✉ Email this page to a colleague

Drug Patents in Algeria and US Equivalents

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Glossary

Subscribe to access the full database, or Sign Up
Patent Number	Estimated Expiration	Equivalent US Patent	US Expiry Date	Generic Name	US Applicant	US Tradename
2493	⤷ Sign Up	6294540	2018-11-14	abacavir sulfate	Viiv Hlthcare	ZIAGEN
2493	⤷ Sign Up	6294540	2018-11-14	abacavir sulfate; lamivudine	Viiv Hlthcare	EPZICOM
2493	⤷ Sign Up	6294540	2018-11-14	abacavir sulfate; lamivudine; zidovudine	Viiv Hlthcare	TRIZIVIR
2371	⤷ Sign Up	5968895	2016-12-11	abarelix	Speciality European	PLENAXIS
>Patent Number	>Estimated Expiration	>Equivalent US Patent	>US Expiry Date	>Generic Name	>US Applicant	>US Tradename

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.